Application 090343
- Type
- ANDA
- Sponsor
- INFORLIFE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | LEVOFLOXACIN | INJECTABLE;INJECTION | EQ 250MG/50ML (EQ 5MG/ML) | No | Yes |
| 002 | LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | LEVOFLOXACIN | INJECTABLE;INJECTION | EQ 500MG/100ML (EQ 5MG/ML) | No | Yes |
| 003 | LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | LEVOFLOXACIN | INJECTABLE;INJECTION | EQ 750MG/150ML (EQ 5MG/ML) | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090343-001 | LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | LEVOFLOXACIN | EQ 250MG/50ML (EQ 5MG/ML) | INJECTABLE / INJECTION | AP | RS | 2011-07-07 |
| A090343-002 | LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | LEVOFLOXACIN | EQ 500MG/100ML (EQ 5MG/ML) | INJECTABLE / INJECTION | AP | RS | 2011-07-07 |
| A090343-003 | LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | LEVOFLOXACIN | EQ 750MG/150ML (EQ 5MG/ML) | INJECTABLE / INJECTION | AP | RS | 2011-07-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090343-001 | AP |
| A090343-002 | AP |
| A090343-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090343-001 | LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | EQ 250MG/50ML (EQ 5MG/ML) | INJECTABLE / INJECTION | AP | RS | 2011-07-07 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090343-002 | LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | EQ 500MG/100ML (EQ 5MG/ML) | INJECTABLE / INJECTION | AP | RS | 2011-07-07 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090343-003 | LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | EQ 750MG/150ML (EQ 5MG/ML) | INJECTABLE / INJECTION | AP | RS | 2011-07-07 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090343-001 | AP | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090343-002 | AP | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090343-003 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levofloxacin | LEVOFLOXACIN | Sagent Pharmaceuticals | 699fbdb8-a6fd-476a-9b80-08197d869534 | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | 090343 ANDA090343 25021-132 |
| Levofloxacin | LEVOFLOXACIN | Hospira, Inc | 5a1534af-aa1c-4f1d-ba9f-9415b14e1af2 | 2025-11-04 | Boxed warning, Warnings, Adverse reactions | 090343 ANDA090343 |
| Levofloxacin | LEVOFLOXACIN | WG Critical Care, LLC | 9020cdeb-65fe-458f-bbbd-69265a49906e | 2024-09-30 | Boxed warning, Warnings, Adverse reactions | 090343 ANDA090343 44567-437 44567-435 44567-436 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 25021-132 | Levofloxacin | Levofloxacin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-132 | Levofloxacin | Levofloxacin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-132 | Levofloxacin | Levofloxacin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-132 | Levofloxacin | Levofloxacin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-132 | Levofloxacin | Levofloxacin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-825 | Levofloxacin | Levofloxacin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-825 | Levofloxacin | Levofloxacin | Sagent Pharmaceuticals | ANDA | Current |
| 44567-435 | Levofloxacin | Levofloxacin | WG Critical Care, LLC | ANDA | Current |
| 44567-435 | Levofloxacin | Levofloxacin | WG Critical Care, LLC | ANDA | Current |
| 44567-435 | Levofloxacin | Levofloxacin | WG Critical Care, LLC | ANDA | Current |
| 44567-435 | Levofloxacin | Levofloxacin | WG Critical Care, LLC | ANDA | Current |
| 44567-436 | Levofloxacin | Levofloxacin | WG Critical Care, LLC | ANDA | Current |
| 44567-436 | Levofloxacin | Levofloxacin | WG Critical Care, LLC | ANDA | Current |
| 44567-436 | Levofloxacin | Levofloxacin | WG Critical Care, LLC | ANDA | Current |
| 44567-436 | Levofloxacin | Levofloxacin | WG Critical Care, LLC | ANDA | Current |
| 44567-437 | Levofloxacin | Levofloxacin | WG Critical Care, LLC | ANDA | Current |
| 44567-437 | Levofloxacin | Levofloxacin | WG Critical Care, LLC | ANDA | Current |
| 44567-437 | Levofloxacin | Levofloxacin | WG Critical Care, LLC | ANDA | Current |
| 44567-437 | Levofloxacin | Levofloxacin | WG Critical Care, LLC | ANDA | Current |